ctrl K

C4 Therapeutics Inc. (CCCC)

NASDAQ: CCCC · Real-Time Price · USD

1.64

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

1.66

1.53%

Pre-market: May 02, 2025, 09:13 AM EDT

C4 Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	35.58M	20.76M	31.1M	45.78M	33.2M	21.38M	19.36M
Cost of Revenue	n/a	117.71M	7.57M	2.91M	77.47M	47.66M	28.59M
Gross Profit	35.58M	-96.95M	23.52M	42.88M	-44.27M	-26.28M	-9.23M
Operating Income	-119.61M	-139.03M	-129.53M	-82.13M	-60.45M	-35.45M	-16.39M
Interest Income	14.43M	9.81M	3.58M	387K	393K	1.83M	685K
Pretax Income	-105.19M	-131.21M	-128.18M	-83.89M	-66.96M	-33.3M	-15.71M
Net Income	-105.32M	-132.49M	-126.5M	-86.04M	-66.33M	-34.1M	-15.71M
Selling & General & Admin	42.12M	42.08M	42.79M	33.25M	15.2M	8.77M	7.16M
Research & Development	110.64M	117.71M	117.84M	94.67M	78.44M	48.06M	28.59M
Other Expenses	2.44M	n/a	n/a	n/a	n/a	325K	-7K
Operating Expenses	155.2M	159.79M	160.63M	127.92M	93.64M	56.83M	35.75M
Interest Expense	n/a	1.37M	2.22M	2.15M	1.23M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	155.2M	159.79M	160.63M	127.92M	93.64M	56.83M	35.75M
Income Tax Expense	131K	1.28M	-1.68M	2.15M	-626K	804K	678K
Shares Outstanding (Basic)	69.37M	49.64M	48.86M	46.04M	43.06M	42.99M	14.79M
Shares Outstanding (Diluted)	69.37M	49.64M	48.86M	46.04M	43.06M	42.99M	42.09M
EPS (Basic)	-1.52	-2.67	-2.59	-1.87	-1.54	-0.79	-1.06
EPS (Diluted)	-1.52	-2.67	-2.59	-1.87	-1.54	-0.79	-1.06
EBITDA	-103.37M	-122.1M	-124.28M	-78.84M	-62.89M	-30.56M	-15.12M
EBIT	-105.19M	-129.84M	-125.96M	-81.75M	-65.73M	-33.3M	-16.39M
Depreciation & Amortization	1.82M	7.74M	7.57M	2.91M	2.84M	2.74M	3.57M